Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Systemic onset juvenile rheumatoid arthritis

R Schneider1, R M Laxer

  • 1Department of Paediatrics, University of Toronto, Ontario, Canada.

Bailliere'S Clinical Rheumatology
|January 16, 1999
PubMed
Summary

Systemic onset juvenile rheumatoid arthritis (SoJRA) is a severe JRA subtype affecting young children. Early diagnosis and management are crucial to prevent long-term complications and improve patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gathering expert consensus to inform a proposed trial in chronic nonbacterial osteomyelitis (CNO).

Clinical immunology (Orlando, Fla.)·2023
Same author

Defining consensus opinion to develop randomised controlled trials in rare diseases using Bayesian design: An example of a proposed trial of adalimumab versus pamidronate for children with CNO/CRMO.

PloS one·2019
Same author

Children with facial morphoea managing everyday life: a qualitative study.

The British journal of dermatology·2018
Same author

Long-term outcome of anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondyloarthritis.

Clinical and experimental rheumatology·2014
Same author

Relapse after systemic treatment in paediatric morphoea.

The British journal of dermatology·2011
Same author

A novel fibrotic disorder associated with increased dermal fibroblast proliferation and downregulation of genes of the microfibrillar network.

The British journal of dermatology·2010

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Internal Medicine

Background:

  • Systemic onset juvenile rheumatoid arthritis (SoJRA) represents 10-20% of juvenile rheumatoid arthritis (JRA) cases.
  • It predominantly affects children under 5 years old, with equal incidence in males and females.
  • Key features include arthritis, daily fever, rash, and serositis, necessitating exclusion of infections, malignancies, and connective tissue diseases.

Purpose of the Study:

  • To provide a comprehensive overview of Systemic Onset Juvenile Rheumatoid Arthritis (SoJRA).
  • To highlight diagnostic challenges and the spectrum of disease severity.
  • To discuss current and emerging therapeutic strategies for SoJRA.

Main Methods:

  • Literature review of SoJRA focusing on clinical presentation, diagnosis, and management.
  • Analysis of disease course variability, from monocyclic to chronic destructive arthritis.
  • Review of pharmacological interventions and potential immunopathogenetic targets.

Main Results:

  • SoJRA presents with diverse extra-articular manifestations and a variable disease course.
  • Approximately one-third of patients develop severe, destructive arthritis.
  • Significant morbidity and mortality are associated with complications like amyloidosis, infections, and macrophage activation syndrome.

Conclusions:

  • Accurate diagnosis of SoJRA requires excluding other serious conditions.
  • Effective management involves a combination of NSAIDs, corticosteroids, methotrexate, and potentially cyclosporine A or cytotoxic drugs.
  • Further research into immunopathogenesis is essential for developing targeted therapies.

Related Experiment Videos